GlycoEra (Series B)
Funding Details
- Awarder
- RSS - techfundingnews.com
- Date Award
- June 02, 2025
- Vertical
- Biotech
- Funding URL
- View Funding Page
- Funding Amount:
- $130,000,000
Company Info
- Founding Year
- 2020
- Founders
- Amir Faridmoayer, Dominique Sirena, Veronica Gambillara Fonck
- Company Description
- Biotech startup GlycoEra pioneers a new class of therapies called extracellular protein degraders. By selectively targeting proteins outside cells, their technology offers a novel therapeutic modality, especially for hard-to-treat autoimmune and inflammatory conditions.
- Market
- Therapeutics
- Location
- Switzerland
- Coinvestors
- Novo Holdings, Catalio Capital Management, LifeArc Ventures, QIA, Sofinnova Partners, 5AM Ventures, Roche Ventures, Bristol Myers Squibb, Agent Capital, MP Healthcare Venture Management, Sixty Degree Capital